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Under the Convention on Biological Diversity (CBD; see
www.cbd.int) countries have sovereign rights over their ge-
netic resources. Agreements governing the access to these
resources and the sharing of the benefits arising from their
use need to be established between involved parties (i.e. Ac-
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ABSTRACT. Will the Convention on Biological Diversity put an end to biological control? Under the Convention on Biological
Diversity countries have sovereign rights over their genetic resources. Agreements governing the access to these resources and the
sharing of the benefits arising from their use need to be established between involved parties. This also applies to species collected
for potential use in biological control. Recent applications of access and benefit sharing principles have already made it difficult or
impossible to collect and export natural enemies for biological control research in several countries. If such an approach is widely
applied it would impede this very successful and environmentally safe pest management method based on the use of biological
diversity. The International Organization for Biological Control of Noxious Animals and Plants has, therefore, created the “Com-
mission on Biological Control and Access and Benefit Sharing”. This commission is carrying out national and international activities
to make clear how a benefit sharing regime might seriously frustrate the future of biological control. In addition, the IOBC Com-
mission members published information on current regulations and perceptions concerning exploration for natural enemies and
drafted some 30 case studies selected to illustrate a variety of points relevant to access and benefit sharing. In this article, we
summarize our concern about the effects of access and benefit sharing systems on the future of biological control.
KEYWORDS. ABS; biological control; CBD; exotic natural enemies; invasive species; legislation; non-monetary benefit sharing.
RESUMO. Poderá a Convenção em Diversidade Biológica por um fim no Controle Biológico? Baseando-se na Convenção sobre
Diversidade Biológica, os países têm soberania sobre seus recursos genéticos. Acordos que governam o acesso a tais recursos e o
compartilhamento dos benefícios provenientes do seu uso precisam ser estabelecidos de comum acordo com as partes envolvidas.
Isto também é aplicável a espécies coletadas com uso potencial em controle biológico. Recentes aplicações dos princípios de
introdução e compartilhamento dos benefícios têm tornado difícil, ou mesmo impossível, coletar e exportar inimigos naturais em
muitos paises para pesquisas em controle biológico em muitos países. Como esta é uma medida amplamente utilizada, tais
procedimentos poderão impedir este bem sucedido e ambientalmente seguro método de manejo de pragas, baseado no uso da
diversidade biológica. A Organização Internacional para Controle Biológico de Plantas e Animais Nocivos (IOBC) criou a “Comissão
em Controle Biológico e Introdução e Benefícios Mútuos” para estudar o assunto. Tal comissão está desenvolvendo atividades
nacionais e internacionais para esclarecer como o regime de compartilhamento de benefícios pode prejudicar seriamente o futuro
do controle biológico. Além disto, membros da Comissão da IOBC publicaram informações sobre regulamentos atuais e suas
opiniões relacionadas à exploração de inimigos naturais, listando cerca de 30 casos para ilustrar os pontos relevantes para a introdução
e compartilhamento de benefícios. No presente artigo, é sumarizado o ponto de vista dessa comissão na IOBC sobre os efeitos dos
sistemas de introdução e compartilhamento para o futuro do Controle Biológico.
PALAVRAS-CHAVE. CDB; compartilhamento de benefícios não lucrativos; controle biológico; espécies invasoras; inimigos naturais
exóticos.
cess and Benefit Sharing (ABS)). This also applies to spe-
cies collected for potential use in biological control. Recent
applications of CBD principles have already made it diffi-
cult or impossible to collect and export natural enemies for
biological control research in several countries. If such an
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approach is widely applied it would impede this very suc-
cessful and environmentally safe pest management method
based on the use of biological diversity.
The CBD was required to agree to a comprehensive
Access and Benefit Sharing process in 2010, in preparation
for which the IOBC (International Organization for Biologi-
cal Control of Noxious Animals and Plants) Global
Commission on Biological Control and Access and Benefit
Sharing prepared and published two documents (a report for
FAO and a scientific paper for BioControl) (Cock 2009, 2010)
to make clear how an ABS regime might seriously frustrate
the future of biological control.
The report prepared at the request of FAO was to summa-
rize the past and current situation regarding the practice of
biological control in relation to the use and exchange of bio-
logical control agents (BCAs) and ABS. The IOBC
Commission members collected information on current regu-
lations and perceptions concerning exploration for natural
enemies and helped draft some 30 case studies selected to
illustrate a variety of points relevant to ABS, ranging from
the difficulties that ABS already represents, to practical ex-
amples of situations where application of ABS is not
straightforward, to successes and the implications for ABS
sharing. In October 2009, the report, which is unique in its
overview of the current state of affairs in biological control,
was published by FAO (Cock et al. 2009). A summary of the
report is presented below and a pdf file of the report can be
downloaded from ftp://ftp.fao.org/docrep/fao/meeting/017/
ak569e.pdf.
The main conclusions of the report were presented by IOBC
Global (www.IOBC-Global.org) during an FAO meeting on
the issue of ABS in October 2009. IOBC representatives ob-
served that country representatives present at the FAO meeting
frequently had not realized (a) how generally biological con-
trol was applied in almost all countries worldwide, (b) that in
classical biological control no direct profits were accrued by
the biological control community performing the work, (c) how
little money was involved in commercial biological control,
and (d) how dependent biological control workers are on ex-
otic natural enemies. Several country representatives requested
more information and documentation about biological control.
The IOBC report to FAO minimized political statements,
to focus on a factual summary. The IOBC Commission on
Biological Control and ABS thought it was essential to present
these issues to the biological control community, as an im-
portant part of this community is still unaware of, or just
beginning to understand the possible implications of ABS.
Therefore, the Commission wrote a forum article for the jour-
nal BioControl, entitled “Do new Access and Benefit Sharing
procedures under the Convention on Biological Diversity
threaten the future of Biological Control?” (Cock et al. 2010).
The full text of the paper, including additional material, can
be downloaded from www.springer.com/life+sci/entomology/
journal/10526 or requested from the authors of this article.
This paper deliberately takes a more political stance and takes
an advocacy role on behalf of the IOBC community. We would
like to stress the importance of the final sentences of this
paper: “Finally, we urge biological control (BC) leaders in
each country to join forces and get in touch with the ABS
contact point for their country as soon as possible, and raise
the issues surrounding the practice of BC and ABS, using
local examples when appropriate, so their national delegates
to the ABS discussions in 2010 are appropriately informed.
Only if the BC community of practice gets involved in the
discussions now, can they expect their needs to be taken into
consideration.”
The IOBC Commission will continue its work with the
drafting of a document describing best practices for ABS in
relation to biological control including guidelines for joint
research that are equitable, but not restrictive.
The IOBC report to FAO “The use and exchange of bio-
logical control agents for food and agriculture”. The report
sets out to summarize the past and current situation regarding
the practice of biological control in relation to the use and ex-
change of genetic resources relevant for BCAs. It considers
the two main categories of biological control: classical and
augmentative. Allowing access to BCAs for use in another
country imposes no risk of liability to the source country. Lo-
cal scientific knowledge about habitats, fauna and flora, can
be helpful for locating suitable sites for surveys and collec-
tions. Biological control is a research-based activity that
requires access to genetic resources but one that is not expected
to generate large monetary returns. It is not the practice in the
biological control sector to patent biological control organisms.
The Research Process and Opportunities for Benefit
Sharing. Preliminary surveys for the target pest and its natural
enemies will often need to be carried out in several coun-
tries. These surveys offer limited opportunities for financial
benefit sharing, but benefit the source country through pro-
vision of training in survey methods, joint surveys, capacity
building and information generated to better understand
biodiversity. Specimens of pests and natural enemies would
normally need to be exported for identification and taxo-
nomic studies.
Detailed studies on natural enemies to assess their poten-
tial as BCAs must in part be carried out in the source country,
while host-specificity studies involving plants or animals not
naturally occurring in the source country would best be car-
ried out in quarantine in the target country or in a third
country. It is this stage of a biological control programme
that provides great scope for collaboration, shared research
and capacity building. In comparison, there is relatively little
scope for routinely sharing research with the source country
during the BCA release stage.
In source countries, local partners are essential to carry
out biological control surveys and research. When added to
the moral obligation in the spirit of ABS, there is a compel-
ling case for local partnerships. Some of these local partners
will become the leaders in developing biological control op-
tions for their country in the future.
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The Implementers. Two main groups of producers are
involved in augmentative biological control: commercial and
centralized. The former are independent companies who pro-
duce and sell BCAs to users. Such companies have mostly
operated in developed countries, but new ones are increas-
ingly common globally, particularly supporting cash crop
production in middle-income countries. The centralized pro-
duction units are government- or industry-owned and produce
natural enemies for a particular niche, normally large-scale
agriculture or forestry, or the natural environment which are
either provided free or sold to users. In the case of classical
biological control, those who implement it are normally na-
tional agencies or programmes. Classical biological control
in developing countries is often carried out with the finan-
cial support of international development agencies and
technical support of implementation agencies.
The Benefits to Users and Their Customers. In the con-
text of agriculture and forestry, the main beneficiaries of
classical biological control are the farmers who have their
pest problems reduced without necessarily actively using
BCAs, which by spreading and reproducing naturally con-
tribute to the public good. The reduced crop losses from pests
lead to improved food security and improved livelihoods.
Farmers in all parts of the world have benefited from this.
Consumers also benefit from reduced use of pesticides, and
hence lower pesticide residues in food. Thus, classical bio-
logical control is in the domain of public good, as the benefits
reach all who grow and benefit from the crop, without requir-
ing them to intervene. The use of augmentative and classical
biological control enables producers to reduce pesticide use
and residues to meet the high standards of profitable north-
ern export markets, resulting in job creation amongst the
growers and a very significant influx of foreign exchange in
developing countries.
To make augmentative biological control products avail-
able in developing countries it is necessary to establish mass-
production facilities, which create job opportunities. Also
important is the creation or retention of jobs in agricultural
production systems dependent upon augmentative or classi-
cal biological control.
Biological control also addresses invasive alien species
that are problems in agriculture, forestry and the environ-
ment. Biological control is an cost-effective tool to tackle
alien pest problems. Furthermore, biological control is envi-
ronmentally friendly and generally does not lead to a reduction
of biodiversity which is often observed when chemical pes-
ticides are used.
The Extent of Use of Biological Control. At least 7000
introductions of BCAs involving almost 2700 BCA species
have been made. The most widely used BCAs have been in-
troduced into more than 50 countries. BCAs from 119
different countries have been introduced into 146 different
countries. High-income countries have implemented classi-
cal biological control the most and have also been the main
source of BCAs. Low-income countries have contributed
slightly more BCAs than they have received.
In augmentative biological control, more than 170 spe-
cies of natural enemies are produced and sold, but some 30
species make up more than 90% of the market worldwide.
There is a trend in augmentative biological control to first
look for indigenous natural enemies when a new, even ex-
otic, pest develops.
Once a BCA has been used successfully in one country
the opportunity has often been taken to repeat that success in
other countries through redistribution of the BCA. Develop-
ing countries have benefited from access to such tested BCAs
because research and implementation was carried out by de-
veloped countries. For example, the work of developed
countries with subtropical and tropical regions, e.g. Austra-
lia and the USA, has directly benefited developing countries
in the tropics and subtropics. Usually BCAs for redistribu-
tion have been re-collected in the target country rather than
the original source country.
Control of Genetic Resources and Opportunities for
Profit. In the case of classical biological control, a national
or international research institute usually carries out the re-
search, but once established, a BCA ceases to be under its
control. The agent breeds and ideally contributes effectively
to management of the target pest. The BCA will disperse to
the geographic range limits to which it is suited, often in-
cluding other countries. The classical biological control ethos
is to establish a free-of-charge public good. The sector has
traditionally made no use of intellectual property rights to
regulate access to, or use of, classical BCAs. All knowledge
generated is put into the public domain, and other countries
are encouraged to take advantage of this new BCA. Benefits
to farmers, consumers, and the local economy, do not return
to the research institute or development agency in monetary
form.
In the case of augmentative biological control, a com-
pany might survey for a useful new BCA to control a
particular pest. They research it and develop rearing, distri-
bution and release methods at their own expense. The
augmentative biological control company then sells it to grow-
ers or other customers, generating profits for the company.
Farmers who paid for the BCA benefit from effective pest
control and improved yields, growing food without pesticides
with implications for their own health, and the price they can
obtain for their produce. The customers who buy the food
are able to get healthy food at an acceptable price. It is not
the practice in the augmentative biological control sector to
use patents for BCAs, so anyone can collect and use the agents
from nature. Augmentative biological control companies may
establish patents on rearing processes, but more usually
handle this by keeping the relevant know-how secret.
Worldwide, some 30 larger commercial producers of aug-
mentative BCAs are active, of which 20 are located in Europe.
In addition to the larger producers, some 100 small commer-
cial producers are active, employing fewer than five people.
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The total market for augmentative biological control natural
enemies at end-user level in 2008 was estimated at about
US$100–135 million. With an average net profit margin of
around 3–5%, the total commercial augmentative biological
control industry profit is under US$15 million per year. Aug-
mentative biological control is a small activity undertaken by
small and medium-sized enterprises and with modest profits.
Regulation of Introduction of Biological Control
Agents. Over the last 20 years, the introduction of BCAs has
increasingly followed international or national legislation.
ISPM3 (International Standards for Phytosanitary Measures
No. 3) of the IPPC (International Plant Protection Conven-
tion) sets out the responsibilities of the different players, but
does not address the issue of ABS.
Since the earliest days of biological control, there has been
a community of practice based on free multilateral exchange
of BCAs, rather than bilateral exchange or defined benefit
sharing agreements. Countries are both providers and users
of BCAs. It has usually made good practical sense to col-
laborate with a research organization in a (potential) source
country, and as the need for more detailed risk and environ-
mental impact assessment studies has grown, the need for
collaborative research in the source country has grown. Con-
versely, there is a general trend for access to genetic resources,
including BCAs, to become increasingly restrictive, for a
variety of reasons, including ABS regulations and, in the case
of biological control, phytosanitary legislation. The existing
multilateral free exchange ethos and effective global network-
ing of biological control practitioners is a foundation that
deserves special consideration with regard to ABS.
New legislation has been and is being introduced in some
countries regarding access to genetic resources. If legislation
is not designed to accommodate biological control, it becomes
a very difficult and challenging process for both international
researchers and their national collaborators. In the short term,
this legislation will remain in place with obligatory compli-
ance. There is a risk that new international ABS legislation
not tailored to the needs of the sector will add another layer of
regulation to the research, which is likely to slow the process.
The arrival of a new invasive alien pest in a country can
be economically or environmentally devastating. In such
cases, there is an argument that an emergency response may
be needed before irreversible harm is done. That emergency
response could be classical biological control. In such cases
fast-track procedures for access to genetic resources should
be anticipated and facilitated.
User Perspectives. The attitudes and views of biological
control players reflect a mixture of positions regarding ABS.
Much of the classical biological control community has been
unaware of the potential of ABS to affect its activities, although
the pragmatic need for a good local collaborator is recognized.
However, there is now growing awareness of ABS policies and
the need for continued exchange of BCAs so that biological
control and the resultant public good will be guaranteed.
The implementers of classical biological control have long
been aware that classical biological control does not bring them
cash benefits. It is against the classical biological control ethos,
which is based on government and donor financing to create a
free-of-charge public good. Furthermore, there is no pathway
or mechanism to collect monetary benefits from the benefi-
ciaries, such as smallholder farmers. For this reason, forms of
non-monetary benefit sharing are appropriate, based around
shared research activities and capacity building.
On the other hand, the augmentative biological control
community has been more aware of the issues, perhaps be-
cause augmentative biological control does generate some
modest commercial profits. Larger augmentative biological
control producers, such as members of the International
Biocontrol Manufacturers Association (IBMA) and the As-
sociation of Natural Biocontrol Producers (ANBP), are
willing to consider benefit sharing in the form of knowledge
sharing, training, provision of natural enemies, and in other
ways. In the event that a natural enemy obtained from a source
country becomes a commercially successful BCA, some aug-
mentative biological control producers foresee that payment
of ‘royalties’ to the country of origin might be possible, but
if the industry had to pay for access to each natural enemy
collected, they would anticipate not being able to continue
with this type of work. On balance, these producers believe
that benefits from shared activities and capacity building
would be a more realistic approach, given the relatively small
profits and profit margins in the augmentative biological
control industry.
Summary of Specific Features of Biological Control.
ABS regulations should recognize the specific features of
biological control: countries providing BCAs are also them-
selves users of this technology; many BCAs are exchanged,
but have little recoverable monetary value; organisms are not
patented, so can be used by anyone at any time; classical
biological control information and to a degree augmentative
biological control information are publicly shared; there are
societal benefits for all, such as environmental and public
health benefits, and reduction in pesticide use; Biological
control is widely used in both developing and developed coun-
tries, often using the same BCAs; most use of biological
control relates to food and agriculture.
Recommendations. In view of these specific positive
features, the following recommendations are made:
1. Governments should build on the existing multilateral
practice of exchange of natural enemies for biological
control on a complementary and mutually reinforcing
basis, which ensures fair and equitable sharing of the
benefits of biological control worldwide.
2. ABS regulations should encourage further development
of the biological control sector, by facilitating the
multilateral exchange of BCAs.
3. Countries are encouraged to have a single point of contact
to facilitate survey missions, provision of information,
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institutional linkages and taxonomic support, and provide
advice on compliance with regulations for biological
control, including ABS.
4. ABS in relation to biological control will normally be based
on non-monetary benefit sharing, e.g. capacity building,
shared research programmes and/or technology transfer,
as already practised by many organizations and the
augmentative biological control industry.
5. A document describing best practices for ABS in relation
to biological control, including guidelines for joint research
that are equitable but not restrictive, should be prepared
and disseminated. Biological control organizations would
be expected to follow these guidelines.
6. To improve transparency in the exchange of BCAs,
mechanisms should be supported globally to establish and
allow free access to database information on BCAs
including source and target countries, e.g. BCANZ in New
Zealand (Ferguson et al. 2007).
7. In the case of a humanitarian or an emergency situation
for food security, governments should cooperate within
FAO to fast track action in the exchange of BCAs.
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Post Scriptum: The Nagoya protocol, biological con-
trol and access and benefit-sharing.
The Convention on Biological Diversity’s access and ben-
efit sharing protocol was agreed on the tenth Conference of
Parties to the CBD at Nagoya, Japan, in October last year,
and is now known as the Nagoya Protocol (UN. 2010. Nagoya
Protocol on Access to Genetic Resources and the Fair and
Equitable Sharing of Benefits Arising from their Utilization
to the Convention on Biological Diversity. http://treaties.
un.org/doc/source/signature/2010/Ch-XXVII-8-b.pdf).
The Nagoya protocol is an agreement between the signa-
tory countries of the CBD as to how access and benefit sharing
of genetic resources (including all biological control agents)
will be handled in future. Based on this protocol, each coun-
try will prepare its own legislation and regulations. Article 8
‘Special Considerations’ of the Nagoya Protocol states:
“In the development and implementation of its access and
benefit-sharing legislation or regulatory requirements, each
Party shall:
(a) Create conditions to promote and encourage research
which contributes to the conservation and sustainable
use of biological diversity, particularly in developing
countries,’ including through simplified measures on
access for non-commercial research purposes, taking
into account the need to address a change of intent for
such research;
(b) Pay due regard to cases of present or imminent emer-
gencies that threaten or damage human, animal or
plant health, as determined nationally or internation-
ally. Parties may take into consideration the need for
expeditious access to genetic resources and expedi-
tious fair and equitable sharing of benefits arising out
of the use of such genetic resources, including access
to affordable treatments by those in need, especially
in developing countries;
(c) Consider the importance of genetic resources for food
and agriculture and their special role for food secu-
rity.”
If it is accepted that biological control is non-commer-
cial research, simplified measures for access and benefit
sharing should facilitate biological control research. Further-
more, the use of biological control to address emergencies
and the needs of food and agriculture should also be facili-
tated. However, in practice, a lot will depend on the legislation
and regulations put in place by each country, and there is still
a risk that if biological control is not accepted as non-com-
mercial research in this process, some countries may
inadvertently make it unnecessarily difficult or even impos-
sible to access biological control agents. The biological
control community in each country is encouraged to have an
input into the legislation and regulation process to encour-
age the facilitation of biological control along with other
non-commercial research activities, e.g. relating to taxonomy,
ecology and conservation.
